StreetInsider.com News Articles

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Thu, 16 Jul 2026 08:00:00 -0400

PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Thu, 16 Jul 2026 08:00:00 -0400

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Thu, 16 Jul 2026 08:00:00 -0400

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

Thu, 16 Jul 2026 08:00:00 -0400

Integra LifeSciences (IART) PT Raised to $19 at Truist Securities

Thu, 16 Jul 2026 07:09:42 -0400

Truist Securities analyst Richard Newitter raised the price target on Integra LifeSciences (NASDAQ: IART) to $19.00 (from $14.00) while maintaining a Hold rating.

BMO Capital Starts Integra LifeSciences (IART) at Market Perform

Thu, 09 Jul 2026 03:05:13 -0400

BMO Capital analyst Vik Chopra initiates coverage on Integra LifeSciences (NASDAQ: IART) with a Market Perform rating and a price target of $19.00.

The analyst comments: “We initiate coverage of IART at Market Perform with a $19 target price. While Essig's return as CEO provides operational continuity and early signs of recovery are encouraging, including a 1Q26 beat and record Integra Skin production, we believe three years of guidance cuts have left IART a show-me story where key catalysts (Braintree restart, SurgiMend relaunch, PMA approvals) remain ahead, and leverage sits above target at 4.1x. Additionally, IART is +46% YTD vs. the

BMO Capital Starts Integra LifeSciences (IART) at Market Perform

Thu, 09 Jul 2026 03:05:13 -0400

BMO Capital analyst Vik Chopra initiates coverage on Integra LifeSciences (NASDAQ: IART) with a Market Perform rating and a price target of $19.00.

Form 4 INTEGRA LIFESCIENCES For: Jul 01 Filed by: Mosebrook Jeffrey

Mon, 06 Jul 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260706/26736221.html

Form 4 INTEGRA LIFESCIENCES For: Jul 01 Filed by: Mosebrook Jeffrey

Mon, 06 Jul 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260706/26736221.html

Form 4 INTEGRA LIFESCIENCES For: Jul 01 Filed by: Singh Harvinder

Mon, 06 Jul 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260706/26736209.html

Form 4 INTEGRA LIFESCIENCES For: Jul 01 Filed by: Singh Harvinder

Mon, 06 Jul 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260706/26736209.html

Form 4 INTEGRA LIFESCIENCES For: Jul 01 Filed by: DAVIS ROBERT T. JR.

Mon, 06 Jul 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260706/26736187.html

Form 4 INTEGRA LIFESCIENCES For: Jul 01 Filed by: DAVIS ROBERT T. JR.

Mon, 06 Jul 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260706/26736187.html

Form 4 INTEGRA LIFESCIENCES For: Jul 03 Filed by: Knight Lea Daniels

Mon, 06 Jul 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260706/26736154.html

Form 4 INTEGRA LIFESCIENCES For: Jul 03 Filed by: Knight Lea Daniels

Mon, 06 Jul 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260706/26736154.html

Integra LifeSciences names Topaz Kirlew chief regulatory officer

Thu, 02 Jul 2026 08:31:55 -0400

Integra LifeSciences Holdings Corporation (Nasdaq: IART) has appointed Topaz Kirlew as corporate vice president and chief regulatory officer, according to a company statement.

Kirlew, who holds a doctorate and master's degree in business administration from Nova Southeastern University, will oversee regulatory strategy, compliance, submissions, and transformation initiatives globally. She had been serving in an interim regulatory leadership role at the company for several months prior to the appointment.

Stuart Essig, chairman and chief executive officer of Integra LifeSciences, commented on the appointment: "Topaz brings deep regulatory experience, sound judgment, and a practical approach to helping the business move forward the right way.

Integra LifeSciences names Topaz Kirlew chief regulatory officer

Thu, 02 Jul 2026 08:31:55 -0400

Integra LifeSciences Holdings Corporation (Nasdaq: IART) has appointed Topaz Kirlew as corporate vice president and chief regulatory officer, according to a company statement.

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Thu, 02 Jul 2026 08:30:00 -0400

Kirlew will lead Integra’s global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.

PRINCETON, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced the appointment of Topaz Kirlew, DBA, MBA, as corporate vice president and chief regulatory officer. Kirlew will lead Integra's global regulatory affairs organization and oversee regulatory strategy, compliance, submissions, and transformation initiatives worldwide.

Kirlew served as the interim regulatory leader for the company over the past several months, leading the global regulatory organization during an

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Thu, 02 Jul 2026 08:30:00 -0400

Kirlew will lead Integra’s global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.

Kirlew served as the interim regulatory leader for the company over the past several months, leading the global regulatory organization during an

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Thu, 02 Jul 2026 08:30:00 -0400

Kirlew will lead Integra’s global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.

Kirlew served as the interim regulatory leader for the company over the past several months, leading the global regulatory organization during an

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Thu, 02 Jul 2026 08:30:00 -0400

Kirlew will lead Integra’s global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution.

Kirlew served as the interim regulatory leader for the company over the past several months, leading the global regulatory organization during an

Integra LifeSciences Announces Key Executive Appointments

Tue, 23 Jun 2026 08:00:00 -0400

Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth

PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (Nasdaq: IART), a global leader in medical technology, today announced several leadership appointments within its commercial organization. These changes are designed to strengthen customer focus, accelerate execution, and support the company’s long-term growth strategy.

Following the recent appointment of Mike McBreen as executive vice president and chief commercial officer, Robert T. Davis Jr. has been appointed executive vice president, Tissue Reconstruction and Distributed Technologies, where

Integra LifeSciences Announces Key Executive Appointments

Tue, 23 Jun 2026 08:00:00 -0400

Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth

Integra LifeSciences Announces Key Executive Appointments

Tue, 23 Jun 2026 08:00:00 -0400

Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth

Integra LifeSciences Announces Key Executive Appointments

Tue, 23 Jun 2026 08:00:00 -0400

Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth